e-learning
resources
Stockholm 2007
Monday 17.09.2007
Delivering respiratory care: the challenges for primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Patients‘ reasons for early discontinuation of inhaled corticosteroids and their disease control
T. Menckeberg, M. Bouvy, M. Bracke, J. Hugtenburg, J. Raaijmakers, H. Leufkens (Utrecht, Amsterdam, Netherlands)
Source:
Annual Congress 2007 - Delivering respiratory care: the challenges for primary care
Session:
Delivering respiratory care: the challenges for primary care
Session type:
Oral Presentation
Number:
1793
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Menckeberg, M. Bouvy, M. Bracke, J. Hugtenburg, J. Raaijmakers, H. Leufkens (Utrecht, Amsterdam, Netherlands). Patients‘ reasons for early discontinuation of inhaled corticosteroids and their disease control. Eur Respir J 2007; 30: Suppl. 51, 1793
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Patients with moderate asthma symptoms may benefit from short-term inhaled corticosteroid monotherapy
Source: Eur Respir J 2007; 30: Suppl. 51, 615s
Year: 2007
Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice
Source: Eur Respir J 2002; 20: Suppl. 38, 212s
Year: 2002
The effects of nebulised bronchodilators and corticosteroids treatment compared with inhaled drug therapy for moderate COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 290s
Year: 2004
Control of persistent asthma patients on inhaled corticosteroids in a real-life setting
Source: Annual Congress 2010 - New insights in the epidemiology of asthma
Year: 2010
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids
Source: Breathe 2010; 6: 365
Year: 2010
Impact of inhaled corticosteroids in patients with cardiovascular disease
Source: Eur Respir Monogr 2020; 88: 251-263
Year: 2020
Asthma control and medication use five years after early or delayed introduction of inhaled corticosteroids in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 34s
Year: 2003
Inhaled corticosteroids and the risk of a first exacerbation in COPD patients
Source: Eur Respir J 2004; 23: 692-697
Year: 2004
Osteoporosis in patients with long-term inhaled corticosteroids treatment
Source: Eur Respir J 2007; 30: Suppl. 51, 613s
Year: 2007
Inhaled antibiotic therapy in patients with severe asthma
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
Budesonide/formoterol for maintenance and relief
vs.
higher dose ICS/LABA therapy: outcomes in patients symptomatic on high-dose inhaled corticosteroids (HDICS)
Source: Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment
Year: 2007
The effectiveness of inhaled steroids as first-line therapy in the treatment of newly detected asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 266s
Year: 2001
Does the choice of ICS/LABA regimen influence exacerbation rates in asthma patients with high as-needed use?
Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma
Year: 2007
Children with mild asthma: do they benefit from inhaled corticosteroids?
Source: Eur Respir J 2002; 20: 1470-1475
Year: 2002
Comparative effectiveness of two different doses of inhaled corticosteroid in triple therapy on exacerbations in patients with severe COPD: a real-world study
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021
The oral corticosteroid sparing effect of omalizumab in paediatric patients with severe chronic asthma
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010
Regular use of inhaled corticosteroids and the long-term prevention of hospitalisation for asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 8s
Year: 2002
Adherence with two types of inhaled corticosteroids as a primary controller regimen in adult asthma patients
Source: Eur Respir J 2002; 20: Suppl. 38, 304s
Year: 2002
Are inhaled corticosteroids increasing the “load” for some patients with COPD?
Source: Eur Respir J, 50 (4) 1701848; 10.1183/13993003.01848-2017
Year: 2017
Duration of systemic corticosteroids treatment in COPD exacerbations
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept